Epperly Melissa B,
Reporting owner on Forms 3, 4 and 5, CIK 1807359.
Epperly Melissa B, reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Roivant Sciences Ltd. CIK 1635088 | director | 1 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. Common Shares | 2026-10-01 | M exercised | +17,750 | $4.46 | 32,704 | Form 4 |
| Roivant Sciences Ltd. Common Shares | 2026-10-01 | S sold | -16,850 | $36.08 | 15,854 | Form 4 |
| Roivant Sciences Ltd. Common Shares | 2026-10-01 | S sold | -900 | $36.57 | 14,954 | Form 4 |
| Roivant Sciences Ltd. Stock Option (Right to Buy), derivative | 2026-10-01 | M exercised | -17,750 | $0 | 151,416 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001807359-26-000018 | Roivant Sciences Ltd. | 2026-10-05 |